KALA BIO Financial Statements 2015-2025 | KALA

Revenue

$3.892

$11.24

$6.362

$6.074

$0.045

Cost Of Goods Sold

$2.56

$4.097

$3.173

$2.008

Gross Profit

$1.332

$7.143

$3.189

$4.066

$0.045

Research And Development Expenses

$22.094

$18.586

$17.653

$11.515

$18.352

$27.275

$29.29

$29.008

$25.029

$11.382

SG&A Expenses

$18.34

$20.567

$65.035

$105.061

$81.068

$65.015

$35.431

$10.867

$7.64

$4.609

Other Operating Income Or Expenses

$-0.549

$-0.51

$-0.35

$5.805

Operating Expenses

$83.038

$137.388

$99.42

$92.29

Operating Income

$-40.983

$-39.663

$-81.706

$-130.245

$-96.231

$-88.224

$-64.721

$-39.875

$-32.669

$-15.946

Total Non-Operating Income/Expense

$2.472

$-2.536

$36.884

$-12.36

$-8.096

$-6.123

$-2.017

$-2.336

$-0.498

$-0.736

Pre-Tax Income

$-38.511

$-42.199

$-44.822

$-142.605

$-104.327

$-94.347

$-66.738

$-42.211

$-33.167

$-16.682

Income Taxes

Income After Taxes

$-38.511

$-42.199

$-44.822

$-142.605

$-104.327

$-94.347

$-66.738

$-42.211

$-33.167

$-16.682

Other Income

Income From Continuous Operations

$-38.511

$-42.199

$-44.822

$-142.605

$-104.327

$-94.347

$-66.738

$-42.211

$-33.167

$-16.682

Income From Discontinued Operations

Net Income

$-38.511

$-42.199

$-44.822

$-142.605

$-104.327

$-94.347

$-66.738

$-42.211

$-33.167

$-16.682

EBITDA

$-39.476

$-38.107

$-79.744

$-127.751

$-94.265

$-86.423

$-64.095

$-39.121

$-32.266

$-15.482

EBIT

$-40.983

$-39.663

$-81.706

$-130.245

$-96.231

$-88.224

$-64.721

$-39.875

$-32.669

$-15.946

Basic Shares Outstanding

Shares Outstanding

Basic EPS

$-10.15

$-17.35

$-29.48

$-108.32

$-99.50

$-138.00

$-124.50

$-185.50

$-1403.50

$-744.50

EPS - Earnings Per Share

$-10.15

$-17.35

$-29.48

$-108.32

$-99.50

$-138.00

$-124.50

$-185.50

$-1403.50

$-744.50